Apollomics, Inc. Company Operational Continuity Update
October 13, 2025 21:22 ET | Source: Apollomics Inc. FOSTER CITY, Calif.,…
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
The fruquintinib and sintilimab combination demonstrated significant PFS improvements in advanced renal…
36-Year-Old Man Given a Second Chance at Life With Advanced Heart Pump
INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old…
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global…
Rocket Doctor Signs Contracts with Major U.S. Insurers, Expanding Access to Over 7 Million Patients Across California and New York
October 08, 2025 08:00 ET | Source: Rocket Doctor AI Inc. Rocket…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN),…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…
Where Empathy Meets Compassion: Championing Alzheimer’s Awareness
This World Alzheimer's Day, doctors, patients and their caregivers gathered for an…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…